[ALNY] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
15-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -8.52%
YoY- -24.48%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 71,681 21,033 37,924 17,454 7,551 24,019 10,847 36.96%
PBT -276,583 -211,080 -142,227 -112,934 -90,721 -43,480 -29,336 45.32%
Tax -398 361 -7,949 -5,217 -6,685 -22,091 3,021 -
NP -276,185 -211,441 -142,227 -112,934 -90,721 -21,389 -32,357 42.93%
Tax Rate - - - - - - - -
Total Cost 347,866 232,474 180,151 130,388 98,272 45,408 43,204 41.55%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -385.30 -1,005.28 -375.03 -647.04 -1,201.44 -89.05 -298.30 4.35%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -2.47 -2.09 -1.48 -1.32 -1.07 -0.28 -0.51 30.05%
EPS Diluted -2.47 -2.09 -1.48 -1.32 -1.07 -0.28 -0.51 30.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.